2nd Annual

Virtual Clinical Trials

May 12-13, 2020

Philadelphia, PA

Event Overview

With growing pricing demands, increased regulatory scrutiny, patent expirations, and generic competition, it’s crucial that R&D departments are able to utilize digital technologies to ensure high-quality clinical trials. The industry is excited about virtual clinical trials, but the adoption curve is still light. As your organization prepares to apply novel technologies to clinical trials, whether they are fully-virtual or hybrid, it’s important to take into consideration how operational activities will perform when the trial is conducted virtually as opposed to a standard brick-and-mortar model.

Conceptualizing virtual trials not simply as a standard study, but as a way of doing things differently, is essential to a successful outcome. Join us to examine how the industry is navigating different models of remote trials and gain best practices for preparing or improving internal infrastructure to support a remote study.

Sheraton Philadelphia University City Hotel

Image

3549 Chestnut St.
Philadelphia, PA 19104
215-387-8000

Hotel Website

Special Event Rate
Coming Soon

Top 5 Reasons to Attend

  1. Learn best practices and mistakes to avoid for a successful virtual study to represent as close to real clinical practice and patient needs.
  2. Discuss how to redesign internal working processes to efficiently support virtual trials
  3. Explore how organizations are overcoming hurdles to IRB approval for virtual consenting
  4. Examine how the industry is thinking about the transformation to virtual trials, and what canhelp stakeholders adopt the change faster
  5. Hear from legal and regulatory experts on state requirements and constraints for using non-approved Investigational Medicinal Products in Interventional Virtual Clinical Trials.

Attendee Profile

This conference is designed for senior leaders and executives in pharmaceutical and biotech companies responsible for:

  • Virtual Trials
  • Remote Monitoring
  • Clinical Innovation
  • Patient Experience
  • Patient Recruitment
  • Trial Design Innovation
  • Clinical Projects
  • Clinical Operations
  • R&D
  • Clinical Supply Chain
  • Clinical Scientific Affairs
  • Outsourcing
  • Clinical Regulatory Affairs
  • Clinical Data Management
  • Clinical Safety
  • Medical Advisors

TWO DAYS OF EDUCATION AND OPPORTUNITY

DON'T MISS IT

REGISTER NOW

2020 Speaker Faculty


Dawn Anderson

Dawn Anderson

Managing Director, Life Sciences Strategy and Operations, R&D Practice
Deloitte

Craig Lipset

Craig Lipset

Head of Clinical Innovation
Pfizer Inc.

Kyle Faget

Kyle Faget

Special Counsel
Foley & Lardner, LLP

Jeff Kingsley

Jeff Kingsley

CEO
IACT Health

Ross Friedberg

Ross Friedberg

General Counsel & Chief Privacy Officer
Doctor on Demand

Monica Chmielewski

Monica Chmielewski

Attorney
Foley & Lardner, LLP

Amir Lahav

Amir Lahav

Digital Medicine and Clinical Innovation Lead
Pfizer

Michael Song

Michael Song

Senior Manager, Drug Delivery and Device Development
MedImmune

Jane Fang

Jane Fang

Director, R&D Information Head for Clinical Biologics
AstraZeneca

Hassan Kadhim

Hassan Kadhim

Director, Head of Clinical Trial Business Capabilities
Bristol-Myers Squibb

Kayla Kostelecky

Kayla Kostelecky

PhD Candidate, Health Care Ethics
Saint Louis University

Terri Ellsworth

Terri Ellsworth

Director of Professional Relations, Patient Advocacy
Accreditation Council for Medical Affairs (ACMA)

MarlaJan Wexler

MarlaJan Wexler

Patient Advocacy & Education

Jonathan Cotliar

Jonathan Cotliar

Chief Medical Officer
Science37

Kelly Conway

Kelly Conway

Patient

John Reites

John Reites

Chief Product Officer & Partner
THREAD

Michelle Smith

Michelle Smith

Product Delivery, Advisor, Technical Center of Excellence
Eli Lilly and Company

Holly Merrill

Holly Merrill

Senior Director, Training & Education
Science 37

Jeffrey Zucker

Jeffrey Zucker

SVP Global Clinical Operations, Site Management & Trial Optimization
Worldwide Clinical Trials

Karen Beyers

Karen Beyers

Senior Director, MAF Clinical Operations
Johnson & Johnson

REGISTRATION PRICING


CONFERENCE ATTENDEE

SUPER EARLY BIRD

Prior to 1/18/20

$1,596

EARLY BIRD

Prior to 3/18/20

$1,796

STANDARD

Prior to Day of Event

$1,996

EVENT DAY

Day of Event

$2,196

Register 2 Attendees, Get 1 Complimentary Registration*!

Interested in sending groups of 7 or more? Contact us directly for pricing.

* Standard Pricing Only

EVENT SPONSORS

SPONSOR THIS EVENT

Contact Michael Goldberg at (561) 221-6202
or mrg@dgevents.com

Exhibit Booth Package Sponsorship

Advertising Package Sponsorship


MEDIA PARTNERS

Image

PREMIER MEDIA PARTNER